Page last updated: 2024-09-03

pre 084 and 3-hydroxyflavone

pre 084 has been researched along with 3-hydroxyflavone in 1 studies

Compound Research Comparison

Studies
(pre 084)
Trials
(pre 084)
Recent Studies (post-2010)
(pre 084)
Studies
(3-hydroxyflavone)
Trials
(3-hydroxyflavone)
Recent Studies (post-2010) (3-hydroxyflavone)
1160733,657842,242

Protein Interaction Comparison

ProteinTaxonomypre 084 (IC50)3-hydroxyflavone (IC50)
Pyruvate kinase PKMHomo sapiens (human)1.75
Cytochrome P450 1B1Homo sapiens (human)0.09
Aurora kinase BHomo sapiens (human)4.29

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cao, T; Guo, CH; Waddington, JL; Zhen, XC; Zheng, LT1

Other Studies

1 other study(ies) available for pre 084 and 3-hydroxyflavone

ArticleYear
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin.
    Acta pharmacologica Sinica, 2020, Volume: 41, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; DEAD-box RNA Helicases; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flavonols; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Morpholines; Oxidopamine; Parkinson Disease; Receptors, sigma; Ribonuclease III; Sigma-1 Receptor; Tamoxifen

2020